Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Abilita Therapeutics, Inc. ("Abilita") today announced a global licensing and multi-target research collaboration with Finnish Orion Corporation ("Orion") focused on the discovery, development and ...

Tyler Perry reminds us that starting therapy is never too late. The director was recently a guest on The View and revealed that he began therapy for the first time at 54. Perry said a question ...

While I’m not a substitute for professional therapy, I can offer comforting advice, coping strategies, and a safe, judgment-free space to express yourself. How are you feeling today?” ...

Iridex (IRIX) announced the publication of a peer-reviewed study in Ophthalmology Therapy. This study highlights the sustained safety and efficacy of MicroPulse Transscleral Laser Therapy in ...

Collaboration leverages Abilita’s pioneering EMP™ antibody discovery platform for challenging multi-span membrane ... Orion has an extensive portfolio of proprietary and generic medicines and consumer ...

Collaboration leverages Abilita's pioneering EMP™ antibody discovery platform for challenging multi-span membrane protein (MMP) targets Orion has an option to license an undisclosed Abilita ...

Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...

The seventh edition of the Year in Review report condenses the topics explored on Marketplace Pulse in 2024. Disruptors from China — Shein and Temu — and Amazon’s reaction to them, the unique shopping ...